GABA-A receptor
6 drugs CNS
5
approved indications
6
Approved Drugs
6
Companies
5
Indications
1
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (6 companies)
✓ All 6 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (5 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
AZURITY 1 drug
Johnson & Johnson 1 drug
SUPERNUS PHARMS 1 drug
By Therapeutic Area
CNS 4 drugs
Other 2 drugs
Drugs by Company PRO
AZURITY 1 drug
Johnson & Johnson 1 drug
SUPERNUS PHARMS 1 drug
UPSHER SMITH LABS 1 drug
SK LIFE 1 drug
ACCORD HLTHCARE 1 drug
By Therapeutic Area
CNS 4 drugs
EPRONTIA, TOPAMAX, TROKENDI XR, QUDEXY XR
Other 2 drugs
XCOPRI, TOPIRAMATE
Indications Treated
EpilepsyPartial-Onset SeizuresGeneralized Tonic-Clonic SeizuresLennox-Gastaut SyndromeMigraine
All Drugs Targeting GABA-A receptor
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| EPRONTIA | AZURITY | 2021 | 5 | CNS |
| TOPAMAX | Johnson & Johnson | 1996 | 5 | CNS |
| TROKENDI XR | SUPERNUS PHARMS | 2013 | 5 | CNS |
| QUDEXY XR | UPSHER SMITH LABS | 2014 | 5 | CNS |
| XCOPRI | SK LIFE | 2019 | 1 | |
| TOPIRAMATE | ACCORD HLTHCARE | 2003 | - |